After the COMET trial: surveillance pathways and a new name for low-risk DCIS
Low-risk DCIS is a breast change that may never become cancer. Trials now show watching it is safe in the short term. The next step is a proper pathway and a name that does not say cancer.
COMET (US) reported two-year outcomes supporting active monitoring of low-risk DCIS; LORIS and LORD add European data. Propose an implementation programme: eligibility criteria, imaging protocol, an endocrine therapy option, a registry with safety stopping rules, and a terminology change tested for its effect on choice.
- Overdiagnosis and false alarms · Finding more cancer is not the same as saving lives. Screening also finds cancers that would never have hurt anyone, and treats them.
Pages like this
not linked directly; found by shared links- IdeaCertified decision aids required for every preference-sensitive cancer decision
Shares Overdiagnosis and false alarms, HR-positive / HER2-negative breast cancer.
- IdeaSet each woman's mammogram interval from her last mammogram, using AI risk
Shares Mammography & tomosynthesis, Overdiagnosis and false alarms, HR-positive / HER2-negative breast cancer.
- IdeaHormone tablets instead of surgery for small breast cancers in the frail over-80s
Shares Overdiagnosis and false alarms, HR-positive / HER2-negative breast cancer.
- IdeaMake skipping radiotherapy the default for very low-risk breast cancer
Shares Overdiagnosis and false alarms, HR-positive / HER2-negative breast cancer.
- TechnologyMirai (MIT breast cancer risk from mammograms)
Shares Mammography & tomosynthesis, HR-positive / HER2-negative breast cancer.
- IdeaOne-stop breast clinics: imaging, biopsy and a preliminary answer in a single visit
Shares Mammography & tomosynthesis, HR-positive / HER2-negative breast cancer.
- PersonMitchell D. Schnall
Shares Mammography & tomosynthesis, HR-positive / HER2-negative breast cancer.
- InstitutionHospital de Amor (Barretos Cancer Hospital)
Shares Mammography & tomosynthesis, HR-positive / HER2-negative breast cancer.